New Results
Broad spectrum capture of clinical pathogens using engineered Fc-Mannose-Binding Lectin (FcMBL) enhanced by antibiotic treatment
Benjamin T. Seiler, Mark Cartwright, Alexandre L.M. Dinis, Shannon Duffy, Patrick Lombardo, David Cartwright, Elana H. Super, Jacqueline Lanzaro, Kristen Dugas, Michael Super, View ORCID ProfileDonald E. Ingber
doi: https://doi.org/10.1101/387589
Benjamin T. Seiler
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
Mark Cartwright
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
Alexandre L.M. Dinis
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
Shannon Duffy
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
Patrick Lombardo
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
David Cartwright
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
Elana H. Super
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
Jacqueline Lanzaro
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
Kristen Dugas
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
Michael Super
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
2Vascular Biology Program, Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
Donald E. Ingber
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, United States of America
2Vascular Biology Program, Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
3Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, United States of America
Article usage
Posted August 08, 2018.
Broad spectrum capture of clinical pathogens using engineered Fc-Mannose-Binding Lectin (FcMBL) enhanced by antibiotic treatment
Benjamin T. Seiler, Mark Cartwright, Alexandre L.M. Dinis, Shannon Duffy, Patrick Lombardo, David Cartwright, Elana H. Super, Jacqueline Lanzaro, Kristen Dugas, Michael Super, Donald E. Ingber
bioRxiv 387589; doi: https://doi.org/10.1101/387589
Broad spectrum capture of clinical pathogens using engineered Fc-Mannose-Binding Lectin (FcMBL) enhanced by antibiotic treatment
Benjamin T. Seiler, Mark Cartwright, Alexandre L.M. Dinis, Shannon Duffy, Patrick Lombardo, David Cartwright, Elana H. Super, Jacqueline Lanzaro, Kristen Dugas, Michael Super, Donald E. Ingber
bioRxiv 387589; doi: https://doi.org/10.1101/387589
Subject Area
Subject Areas
- Biochemistry (11739)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17409)
- Clinical Trials (138)
- Developmental Biology (9419)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12238)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28068)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)